EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237 | -89.6% | 15 | -87.2% | 0.00% | – |
| Q2 2023 | $2,275 | -77.7% | 117 | -67.4% | 0.00% | – |
| Q1 2023 | $10,184 | -44.3% | 359 | -42.7% | 0.00% | – |
| Q4 2022 | $18,298 | +66.3% | 626 | +50.5% | 0.00% | – |
| Q3 2022 | $11,000 | -69.4% | 416 | -47.7% | 0.00% | – |
| Q2 2022 | $36,000 | -18.2% | 796 | -9.2% | 0.00% | – |
| Q1 2022 | $44,000 | -24.1% | 877 | -23.0% | 0.00% | – |
| Q4 2021 | $58,000 | -7.9% | 1,139 | -0.4% | 0.00% | – |
| Q3 2021 | $63,000 | +75.0% | 1,144 | +36.2% | 0.00% | – |
| Q2 2021 | $36,000 | +9.1% | 840 | +6.9% | 0.00% | – |
| Q1 2021 | $33,000 | -23.3% | 786 | -13.9% | 0.00% | – |
| Q4 2020 | $43,000 | +38.7% | 913 | +26.3% | 0.00% | – |
| Q3 2020 | $31,000 | +24.0% | 723 | +39.6% | 0.00% | – |
| Q2 2020 | $25,000 | -7.4% | 518 | -11.8% | 0.00% | – |
| Q1 2020 | $27,000 | -47.1% | 587 | -31.1% | 0.00% | – |
| Q4 2019 | $51,000 | -95.8% | 852 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $1,215,000 | -27.9% | 21,464 | -29.1% | 0.00% | -50.0% |
| Q2 2019 | $1,685,000 | +5165.6% | 30,264 | +4614.0% | 0.00% | – |
| Q1 2019 | $32,000 | +220.0% | 642 | +156.8% | 0.00% | – |
| Q4 2018 | $10,000 | -47.4% | 250 | -7.7% | 0.00% | – |
| Q3 2018 | $19,000 | -9.5% | 271 | 0.0% | 0.00% | – |
| Q2 2018 | $21,000 | +200.0% | 271 | +113.4% | 0.00% | – |
| Q1 2018 | $7,000 | -89.7% | 127 | -90.1% | 0.00% | – |
| Q4 2017 | $68,000 | +1.5% | 1,281 | +13.4% | 0.00% | – |
| Q3 2017 | $67,000 | -92.5% | 1,130 | -90.0% | 0.00% | -100.0% |
| Q2 2017 | $889,000 | -4.2% | 11,269 | +0.7% | 0.00% | 0.0% |
| Q1 2017 | $928,000 | -59.0% | 11,187 | -60.8% | 0.00% | -66.7% |
| Q4 2016 | $2,262,000 | -21.2% | 28,520 | -30.4% | 0.00% | 0.0% |
| Q3 2016 | $2,871,000 | +488.3% | 41,002 | +226.0% | 0.00% | +200.0% |
| Q2 2016 | $488,000 | -1.2% | 12,578 | +2.9% | 0.00% | 0.0% |
| Q1 2016 | $494,000 | -38.4% | 12,229 | +35.1% | 0.00% | 0.0% |
| Q4 2015 | $802,000 | +15.6% | 9,051 | -3.6% | 0.00% | 0.0% |
| Q3 2015 | $694,000 | -5.6% | 9,388 | +3.3% | 0.00% | 0.0% |
| Q2 2015 | $735,000 | – | 9,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |